Report

Carclo plc: High growth stock trading >30% below SOTP valuation

Carclo is a leading global designer and contract manufacturer (FY17 sales 70% non-UK) of fine tolerance and often mission/safety critical components for the medical (46%), optics (5%), aerospace (5%) and luxury/supercar (27%) markets. Carclo has shown that you don’t have to be a ‘Silicon Valley’ tech start-up to deliver double-digit top line growth, as the group has been doing exactly this for years.

Its strategy of dove-tailing front-end innovative design, prototyping and tooling capability, with back-end flexible manufacturing, global coverage and supply chain expertise, is proving a winning formula. In turn, helping to propel FY17 revenues to £138.3m (+16.2%, or 10% constant currency), EPS up 20% (12.1p) and EBIT margins to 9.0% (vs 8.4% LY).

Better still, the vast majority of these volumes are tied to OEM platforms with typical life-spans of between 5-20 years. Hence providing excellent forward visibility and predictable earnings. We think the momentum (12.4% pa sales CAGR) built up over the past 4 years should continue - underpinned by the production of long-cycle end-user products, low client churn and secular growth.

Our forecast revenues are set to expand at a 10% pa clip over the next 4 years, and even accelerate slightly once Wipac’s new mid-volume LED contracts come on stream from late 2019 onwards. EPS is predicted to jump 68% from 12.1p in FY17 to 20.3p by FY21, on turnover up 46% from £138.3m to £202.5m.

Encouragingly for income seekers, the Board recognises the importance of sustainable and progressive dividends. After a suspension due to pension considerations affecting distributable reserves, the resumption of payments has been pencilled in for 12 months’ time.

The stock at 152p appears lowly rated, trading on PER and EV/EBIT multiples of 11.9x and 9.8x respectively vs peer averages of >20x and c. 16x-17x.We calculate there is >30% disparity versus our 200p/share sum-of-the-parts valuation.
Underlying
Provider
Equity Development
Equity Development

​Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.

Analysts
Paul Hill

Other Reports on these Companies
Other Reports from Equity Development

ResearchPool Subscriptions

Get the most out of your insights

Get in touch